6348 related articles for article (PubMed ID: 18780655)
1. [Immunohistochemical detection of the gene p53 and p21 expression in cells of the malignant melanoma of the uvea].
Tokosová E; Hermanová M; Uhmannová R; Smardová J; Hlinomazová Z
Cesk Slov Oftalmol; 2008 Jul; 64(4):153-6. PubMed ID: 18780655
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
4. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and p21 in primary glioblastomas.
Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
[TBL] [Abstract][Full Text] [Related]
6. [Malignant melanoma of the uvea in the Department of Ophthalmology, Faculty Hospital Brno Bohunice, Czech Republic, EU].
Tokosová E; Uhmannová R; Hlinomazová Z
Cesk Slov Oftalmol; 2008 Jan; 64(1):30-3. PubMed ID: 18225497
[TBL] [Abstract][Full Text] [Related]
7. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p53 is a late event in the development of malignant melanoma.
Lassam NJ; From L; Kahn HJ
Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708
[TBL] [Abstract][Full Text] [Related]
9. Significance of p53 expression in immature teratomas.
Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS
Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994
[TBL] [Abstract][Full Text] [Related]
10. p53 plays a central role in UVA and UVB induced cell damage and apoptosis in melanoma cells.
Zhang H
Cancer Lett; 2006 Dec; 244(2):229-38. PubMed ID: 16504377
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma.
Knopf A; Plettenberg C; Pickhard A; Bas M; Reifenberger J; Bier H; Balz V
Melanoma Res; 2011 Oct; 21(5):380-8. PubMed ID: 21691232
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific expression of p53 and p21 in giant cell arteritis.
Nordborg C; Aman P; Persson M; Nordborg E
APMIS; 2005 Sep; 113(9):594-9. PubMed ID: 16218934
[TBL] [Abstract][Full Text] [Related]
14. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
15. Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.
Okamoto I; Pirc-Danoewinata H; Ackermann J; Drach J; Schlagbauer Wadl H; Jansen B; Wolff K; Pehamberger H; Marosi C
Br J Cancer; 1999 Jan; 79(1):131-7. PubMed ID: 10408704
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16 in sporadic primary uveal melanoma.
Lamperska K; Mackiewicz K; Kaczmarek A; Kwiatkowska E; Starzycka M; Romanowska B; Heizman J; Stachura J; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):377-85. PubMed ID: 12362979
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of tumoral suppressor p53 gene in lung adenocarcinomas.
Cornianu M; Tudose N; Potencz E; Lazăr E
Rom J Morphol Embryol; 1996; 42(1-2):73-82. PubMed ID: 9038389
[TBL] [Abstract][Full Text] [Related]
18. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
[TBL] [Abstract][Full Text] [Related]
19. GPNMB expression in uveal melanoma: a potential for targeted therapy.
Williams MD; Esmaeli B; Soheili A; Simantov R; Gombos DS; Bedikian AY; Hwu P
Melanoma Res; 2010 Jun; 20(3):184-90. PubMed ID: 20375921
[TBL] [Abstract][Full Text] [Related]
20. Expression of p21 and p53 in rat gingival and human oral epithelial cells after cyclosporine A treatment.
Tu HP; Fu E; Chen YT; Wu MH; Cheng LC; Yang SF
J Periodontal Res; 2008 Feb; 43(1):32-9. PubMed ID: 18230104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
